XML 60 R46.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SHARE-BASED PAYMENTS - Schedule of Share-based Compensation, Restricted Stock, Restricted Stock Units Activity and SAR's (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Payment Arrangement, Expense $ 1,412 $ 1,554 $ 2,757 $ 2,740
Equity Option        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 4.11  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 3.56   $ 3.56  
Employee Stock Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Payment Arrangement, Expense $ 463 88 $ 911 194
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Unrecognized Compensation Costs Related To Unvested Stock Options     1,260  
Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Payment Arrangement, Expense $ 838 1,162 $ 1,582 1,806
Restricted Stock Units (RSUs) | Equity Option        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]        
Number of nonvested shares, beginning of period (in shares)     641,839  
Granted, nonvested, number of shares (in shares)     375,384  
Vested, number of shares (in shares)     (373,067)  
Forfeited, number of shares (in shares)     0  
Number of nonvested shares, end of period (in shares) 644,156   644,156  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 6.57  
Granted, nonvested, weighted average grant date fair value (in dollars per share)     7.47  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     0  
Vested, weighted average grant date fair value (in dollars per share)     6.20  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 7.31   $ 7.31  
Stock Appreciation Rights (SARs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Payment Arrangement, Expense $ 111 $ 304 $ 264 $ 740
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]        
Number of nonvested shares, beginning of period (in shares)     1,839,528  
Granted, nonvested, number of shares (in shares)     0  
Exercised, number of shares (in shares)     (250,036)  
Forfeited, number of shares (in shares)     (3,152)  
Expired (in shares)     (569,595)  
Number of nonvested shares, end of period (in shares) 1,016,745   1,016,745  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 5.01  
Granted, nonvested, weighted average grant date fair value (in dollars per share)     0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercised, Weighted Average Exercise Price     2.92  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     7.36  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expired, Weighted Average Grant Date Fair     2.94  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 6.67   $ 6.67  
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Number 0   0  
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price $ 0   $ 0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms     2 years 9 months 18 days  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $ 0   $ 0  
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value $ 0   $ 0  
Stock Appreciation Rights (SARs) | Equity Option        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]        
Number of nonvested shares, beginning of period (in shares)     1,589,492  
Granted, nonvested, number of shares (in shares)     0  
Vested, number of shares (in shares)     0  
Forfeited, number of shares (in shares)     (3,152)  
Expired (in shares)     (569,595)  
Number of nonvested shares, end of period (in shares) 1,016,745   1,016,745  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 2.89  
Granted, nonvested, weighted average grant date fair value (in dollars per share)     0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     3.45  
Vested, weighted average grant date fair value (in dollars per share)     0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expired, Weighted Average Grant Date Fair     4.51  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 3.83   $ 3.83